Efficacy of adjuvant Immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2006-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00262-005-0054-1PMID 16133112PMCID PMC11030578
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

  2004cited by this paper
• Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: identification of responders incorporating the age factor.

  2004cited by this paper
• Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study

  2004influential reference
• Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer

  2004cited by this paper
• Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up.

  2004cited by this paper
• Christianity and Democracy: The Global Picture

  2004cited by this paper
• Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials.

  2004cited by this paper
• Gene expression in response to anti-tumour intervention by polysaccharide-K (PSK) in colorectal carcinoma cells.

  2004cited by this paper
• [Effect of PSK on Th1/Th2 balance in tumor-bearing mice].

  2003cited by this paper
• Adjuvant Therapy With Protein-Bound Polysaccharide K and Tegafur Uracil in Patients With Stage II or III Colorectal Cancer: Randomized, Controlled Trial

  2003influential reference
• A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines.

  2003cited by this paper
• Efficacy of Adjuvant Immunochemotherapy With OK-432 for Patients With Curatively Resected Gastric Cancer: A Meta-Analysis of Centrally Randomized Controlled Clinical Trials

  2002cited by this paper
• Immunomodulatory Effects of Low Dose cis-Diaminedichloroplatinum (Cisplatin) Combined with UFT and PSK in Patients with Advanced Colorectal Cancer

  2002cited by this paper
• Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival.

  2002cited by this paper
• Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.

  2002cited by this paper
• Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.

  2002cited by this paper
• PSK, a protein-bound polysaccharide, overcomes defective maturation of dendritic cells exposed to tumor-derived factors in vitro.

  2002cited by this paper
• Meta-analysis of adjuvant immunochemotherapy using OK-432 in patients with resected non-small-cell lung cancer.

  2001cited by this paper
• Meta-analysis of Adjuvant Immunochemotherapy Using OK-432 in Patients With Resected Non-Small-Cell Lung Cancer

  2001cited by this paper
• Cancer burden in the year 2000. The global picture.

  2001influential reference
• A CASE REPORT OF JUVENILE COLON CANCER

  2000cited by this paper
• The use of mushroom glucans and proteoglycans in cancer treatment.

  2000cited by this paper
• Long-term survival after immunochemotherapy for juvenile colon cancer with peritoneal dissemination: a case report.

  2000cited by this paper
• Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon.

  2000cited by this paper
• Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials.

  1999cited by this paper
• Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line

  1999cited by this paper
• Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

  1998cited by this paper
• The efficacy of immunochemotherapy with strontium (Sr) in the 1,2-dimethylhydrazine (DMH) induced rat carcinogenetic model: ultrastructural characteristics of the mitochondria in the liver.

  1998cited by this paper
• [Surgery and multidisciplinary treatment for colorectal cancer].

  1998cited by this paper
• Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-beta.

  1998cited by this paper
• A Case of Juvenile Colon Cancer.

  1997cited by this paper
• Oral administration of psk can improve the impaired anti‐tumor CD4+ T‐cell response in gut‐associated lymphoid tissue (GALT) of specific‐pathogen‐free mice

  1997cited by this paper
• Direct Tumor Growth Suppressive Effect of Melanoidin Extracted from Immunomodulator-PSK

  1997cited by this paper
• Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.

  1997cited by this paper
• Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma: Findings from three independent clinical trials

  1996cited by this paper
• [Locoregional therapy for liver metastases of colorectal cancer].

  1996cited by this paper
• Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.

  1996cited by this paper
• Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview.

  1995cited by this paper
• [Antitumor effect of intratumoral administration of BRM: inhibition of tumor cell invasion in vitro].

  1995cited by this paper
• Induction of gene expression for immunomodulating cytokines in peripheral blood mononuclear cells in response to orally administered PSK, an immunomodulating protein-bound polysaccharide

  1995cited by this paper
• In vitro reactivity to a protein-bound polysaccharide PSK of peripheral blood lymphocytes from patients with gastrointestinal cancer.

  1995cited by this paper
• Polysaccharide preparation PSK augments the proliferation and cytotoxicity of tumor-infiltrating lymphocytes in vitro.

  1995cited by this paper
• Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K

  1995cited by this paper
• Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.

  1994cited by this paper
• Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK.

  1994cited by this paper
• Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer

  1994cited by this paper
• Enhancement of the antitumor effect by the concurrent use of a monoclonal antibody and the protein-bound polysaccharide PSK in mice bearing a human cancer cell line.

  1994cited by this paper
• Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer

  1992cited by this paper
• Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).

  1992influential reference
• Randomized, controlled study on adjuvant immunochemotherapy with PSK® in curatively resected colorectal cancer

  1992influential reference
• Antitumor Effect of PSK at a Distant Site: Tumor‐specific Immunity and Combination with Other Chemotherapeutic Agents

  1992cited by this paper
• [Immunological competence and effect of PSK in patients with gastric cancer and colon cancer: preliminary report].

  1992cited by this paper
• [A case of rectal carcinoma disappeared by the preoperative radiation].

  1991cited by this paper
• Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: enhancement of the activity by a polysaccharide preparation, krestin.

  1991cited by this paper
• Alternating immunochemotherapy of advanced gastric carcinoma: A randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection

  1991cited by this paper
• Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

  1990cited by this paper
• Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer

  1990influential reference
• Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells.

  1990cited by this paper
• [Comparison of surgical therapy and combined irradiation in rectal cancer--first report, effect of irradiation on the tumor. Study Group of Surgical Therapy and Combined Irradiation in Rectal Cancer].

  1989cited by this paper
• Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.

  1989cited by this paper
• [An autopsy case of rectal cancer receiving cisplatin at total dose of 3.250 mg and platinum concentrations in autopsy tissue samples].

  1989cited by this paper
• [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum].

  1989cited by this paper
• [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku].

  1988cited by this paper
• Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin).

  1988cited by this paper
• [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].

  1987cited by this paper
• [Restoration of immunologic responsiveness by PSK in tumor-bearing animals].

  1986cited by this paper
• [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].

  1986cited by this paper
• [Surgery and adjuvant therapy of cancer of the large intestine].

  1986cited by this paper
• [Regression of adenomas in Gardner's syndrome induced by systemic chemotherapy].

  1984cited by this paper
• [A study on postoperative long-term continuous immuno-chemotherapy with PSK and 5-FUDS for advanced gastric and colo-rectal cancers].

  1983cited by this paper

• From nature to clinic: Lessons from successfully marketed polysaccharide drugs

  2026cites this paper
• De novo transcriptome analyses of medicinal mushrooms reveal potential genes in polysaccharide biosynthesis

  2026cites this paper
• Fungal Derived Supplements in Integrative Oncology.

  2026cites this paper
• Beyond biologics: fungal polysaccharides as dual-function materials for nanomedicine.

  2025cites this paper
• Polysaccharide-based drug delivery targeted approach for colon cancer treatment: A comprehensive review.

  2025cites this paper
• Die Rolle von Heilpilzen in der Integrativen Onkologie

  2025cites this paper
• Exploring the Anticancer Potential of Coriolus versicolor in Breast Cancer: A Review

  2025cites this paper
• Experimental Models in Unraveling the Biological Mechanisms of Mushroom-Derived Bioactives against Aging- and Lifestyle-Related Diseases: A Review

  2024cites this paper
• Protein-Bound Polysaccharide K (PSK)-Rich Extract of Lentinus Polychrous Exhibits Anticancer Activity by Apoptosis Induction and Cell Cycle Arrest in Cholangiocarcinoma Cells

  2024cites this paper
• Natural polysaccharides-based postbiotics and their potential applications

  2024cites this paper
• Welche Phytotherapeutika werden in medizinischen Leitlinien zur Behandlung gastroenterologischer Erkrankungen berücksichtigt?* 

  2024cites this paper
• Phytotherapeutische Empfehlungen in medizinischen Leitlinien zur Behandlung gastroenterologischer Erkrankungen – ein systematischer Überblick

  2023cites this paper
• A Comprehensive Review on Phytochemical Profiling in Mushrooms: Occurrence, Biological Activities, Applications and Future Prospective

  2023cites this paper
• Edible mushrooms: Nutritional composition and medicinal benefits for improvement in quality life

  2022cites this paper
• Mycomedicinals (Mushrooms) for Cancer

  2022cites this paper
• Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer.

  2022cites this paper
• Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis

  2022cites this paper
• Coriolus versicolor and its bioactive molecule are potential immunomodulators against cancer cell metastasis via inactivation of MAPK pathway.

  2022cites this paper
• Mushroom Polysaccharide-Assisted Anticarcinogenic Mycotherapy: Reviewing Its Clinical Trials

  2022cites this paper
• Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review.

  2022cites this paper
• Immunstimulanzien aus der Naturheilkunde und ihr Einsatz bei Neoplasien

  2021cites this paper
• Significance of Medicinal Mushrooms in Integrative Oncology: A Narrative Review

  2020cites this paper
• Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer

  2020cites this paper
• Immunomodulatory Activity of Natural Polysaccharides in Combating Covid -19, Cancer, Inflammatory Disorders: A Review

  2020cites this paper
• The use of Hericium erinaceus and Trametes versicolor extracts in supportive treatment in oncology

  2020cites this paper
• Mushrooms as Potential Natural Cytostatics

  2019cites this paper
• An overview of fungal glycan-based therapeutics.

  2019cites this paper
• Herbal Medicines as Adjuncts to Cancer Chemotherapy—Part 1: Immunomodulators

  2019cites this paper
• Integrative Oncology

  2019cites this paper
• Cancer immunotherapy: Role of the immune system in malignant transformation

  2019cites this paper
• Clinical trial comparing UFT-PSK combination adjuvant therapy and surgery-alone for Stage II rectal cancer

  2017cites this paper
• Immunostimulatory and anti-metastatic activity of polysaccharides isolated from byproducts of the corn starch industry

  2017cites this paper
• Randomized phase III trial comparing surgery alone to UFT + PSK for stage II rectal cancer (JFMC38 trial)

  2017cites this paper
• Medicinal Mushrooms in Human Clinical Studies. Part I. Anticancer, Oncoimmunological, and Immunomodulatory Activities: A Review.

  2017cites this paper
• S3-Leitlinie – Kolorektales Karzinom

  2017cites this paper
• Biological and pharmaceutical activities of mushroom β-glucan discussed as a potential functional food ingredient

  2017cites this paper
• Kobe University Repository : Kernel タイトル Tit le Potent ial ant itumor act ivity of a low-molecular-weight protein fract ion from Grifola frondosa through enhancement of cytokine product ion 著者

  2017cites this paper
• Preclinical Antileukemia Activity of Tramesan: A Newly Identified Bioactive Fungal Metabolite

  2017cites this paper
• Health Benefits of Edible Mushrooms Focused on Coriolus versicolor : A Review

  2016cites this paper
• Coriolus versicolor mushroom for colorectal cancer treatment

  2016cites this paper
• Complementary and alternative medicine use by cancer patients commencing curative-intent chemotherapy: survey and educational intervention

  2016cites this paper
• Coriolus versicolor mushroom polysaccharides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways.

  2015cites this paper
• Recent progress in fungus-derived bioactive agents for targeting of signaling machinery in cancer cells

  2015cites this paper
• Significant Correlation between TLR2 Agonist Activity and TNF-α Induction in J774.A1 Macrophage Cells by Different Medicinal Mushroom Products.

  2015cites this paper
• Preoperative administration of polysaccharide Kureha and reduced plasma transforming growth factor-β in patients with advanced gastric cancer: A randomized clinical trial.

  2015cites this paper
• Recent progress in fungus-derived bioactive agents for targeting of signaling machinery in cancer cells

  2015cites this paper
• Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?

  2014cites this paper
• Dietary Polysaccharides and Immune Modulation

  2014cites this paper
• Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation

  2014cites this paper
• and Immune Modulation

  2014cites this paper
• Chinese FDA Approved Fungal Glycan-Based Drugs: An Overview of Structures, Mechanisms and Clinical Related Studies

  2014cites this paper
• Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.

  2013cites this paper
• Prognostic markers for immunochemotherapy using tegafur -uracil (UFT) and protein-bound polysaccharide K (PSK).

  2013cites this paper
• Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK

  2013cites this paper
• The effect of polysaccharide k with S-1 based chemotherapy in advanced gastric cancer.

  2013cites this paper
• The expression of integrins is decreased in colon cancer cells treated with polysaccharide K.

  2013cites this paper
• Protein-bound polysaccharide K reduced the invasive ability of colon cancer cell lines.

  2013cites this paper
• Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer.

  2013cites this paper
• 16 – Complementary and Alternative Medicine for Cancer: The Good, the Bad, and the Dangerous

  2013cites this paper
• S3-Leitlinie Kolorektales Karzinom Version 1.0 – Juni 2013 AWMF-Registernummer: 021/007OL

  2013cites this paper
• Nutrition in oncologic patients during antiblastic treatment.

  2013cites this paper
• [S3-guideline colorectal cancer version 1.0].

  2013cites this paper
• Polysaccharide-K (PSK) in cancer--old story, new possibilities?

  2012cites this paper
• Protein-bound polysaccharide-K (PSK) induces apoptosis via p38 mitogen-activated protein kinase pathway in promyelomonocytic leukemia HL-60 cells.

  2012cites this paper
• Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer.

  2012cites this paper
• The role of edible mushrooms in health: Evaluation of the evidence

  2012cites this paper
• Direct inhibition of the transforming growth factor‐β pathway by protein‐bound polysaccharide through inactivation of Smad2 signaling

  2012cites this paper
• Evidence-based Materia Medica for Cancer Chemoprevention

  2012cites this paper
• Evidence-based Anticancer Materia Medica for Lymphoma

  2012cites this paper
• Immunotherapy eradicates metastases with reversible defects in MHC class I expression

  2011cites this paper
• Biological mechanism and clinical effect of protein-bound polysaccharide K (KRESTIN®): review of development and future perspectives

  2011cites this paper
• A review of the anti-tumor effect of the combined administration of a cyclooxygenase-2 selective inhibitor and a non-specific immunostimulant protein-bound polysaccharide on an advanced colon cancer model using colon cancer cell lines.

  2011cites this paper
• An Evidence-based Perspective of Coriolus Versicolor (Multicolored Polypore Mushroom) for Cancer Patients

  2011cites this paper
• Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate cancer

  2011cites this paper
• Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy TLR2 Agonist PSK Activates Human NK Cells and Enhances the

  2011cites this paper
• TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy

  2011cites this paper
• Successful treatment of recurrent small bowel adenocarcinoma by cytoreductive surgery and chemotherapy: a case report and review of the literature

  2010cites this paper
• Total synthesis and cytotoxicity evaluation of all ochratoxin A stereoisomers.

  2010cites this paper
• Ongoing Colorectal Cancer Adjuvant Trials in Japan

  2010cites this paper
• Challenges Conducting Clinical Trials with Herbal Products in Oncology

  2010influential citation
• Flavone effects on the proteome and transcriptome of colonocytes in vitro and in vivo and its relevance for cancer prevention and therapy

  2010cites this paper
• Cancer Therapy : Preclinical Polysaccharide Krestin Is a Novel TLR 2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD 8 T Cells and NK Cells

  2010cites this paper
• Potential Antitumor Activity of a Low-Molecular-Weight Protein Fraction from Grifola frondosa Through Enhancement of Cytokine Production

  2010cites this paper
• PSK enhances the efficacy of docetaxel in human gastric cancer cells through inhibition of nuclear factor-kappaB activation and survivin expression.

  2010cites this paper
• New oligo-beta-(1,3)-glucan derivatives as immunostimulating agents.

  2010cites this paper
• Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells

  2010cites this paper
• A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.

  2009cites this paper
• Complementary therapies, herbs, and other OTC agents.

  2009cites this paper
• Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.

  2008cites this paper
• Trametes versicolor mushroom immune therapy in breast cancer.

  2008cites this paper
• Immunochemotherapy with PSK and Fluoropyrimidines Improves Long-Term Prognosis for Curatively Resected Colorectal Cancer

  2008cites this paper
• Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage II colorectal cancer.

  2008cites this paper
• Protein-Bound Polysaccharide K Partially Prevents Apoptosis of Circulating T Cells Induced by Anti-Cancer Drug S-1 in Patients with Gastric Cancer

  2008cites this paper
• Complementary Therapies and Cancer Treatment

  2008cites this paper
• Advances in immunotherapy for colorectal malignancies

  2008cites this paper
• Dietary supplement use in cancer care: help or harm.

  2008cites this paper
• The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis

  2008cites this paper
• Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration.

  2008cites this paper
• Potentiation of Histamine Release by Microfungal (1→3)‐ and (1→6)‐β‐D‐Glucans

  2007cites this paper
• Potentiation of histamine release by Microfungal (1-->3)- and (1-->6)-beta-D-glucans.

  2007cites this paper